“Detection of factor viii and ix inhibitors in patients receiving lyophilized coagulation factors as prophylaxis or treatment”, REMCB, vol. 38, no. 2, pp. 121–126, Nov. 2017, doi: 10.26807/remcb.v38i2.545.